<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                                      Human Molecular Genetics, 2013, Vol. 22, No. 24               4967&#226;&#8364;&#8220;4977 <br />                                                                       doi:10.1093/hmg/ddt344 <br />                                                                       Advance Access published July 19, 2013 <br />  <br />  <br /> MYBPC1 mutations impair skeletal muscle function <br /> in zebrafish models arthrogryposis <br /> Kyungsoo Ha1, Jillian G. Buchan2, David M. Alvarado1, Kevin Mccall1, Anupama Vydyanath4, <br /> Pradeep K. Luther4, Matthew I. Goldsmith3, Matthew B. Dobbs1,5 Christina A. Gurnett1,2,3,&#226;&#710;&#8212; <br /> 1 <br />  Department Orthopaedic Surgery, 2Department Neurology 3Department Pediatrics, Washington University <br /> School Medicine, St. Louis, MO, USA, 4Heart Lung Institute, Imperial College, London, UK 5St. Louis Shriners <br /> Hospital Children, St. Louis, MO, USA <br />  <br /> Received April 22, 2013; Revised July 9, 2013; Accepted July 16, 2013 <br />  <br />  <br /> Myosin-binding protein C1 (MYBPC1) abundant skeletal muscle protein expressed predominantly in <br /> slow-twitch muscle fibers. Human MYBPC1 mutations associated distal arthrogryposis type 1 lethal <br /> congenital contracture syndrome type 4. As MYBPC1 function incompletely understood, mechanism by <br /> which human mutations result contractures unknown. Here, demonstrate using antisense morpholino <br /> knockdown, mybpc1 required embryonic motor activity <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-5' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span>survival</span> zebrafish model arthrogry- <br /> posis. Mybpc1 morphant embryos severe body curvature, cardiac edema, impaired motor excitation and <br /> are delayed hatching. Myofibril organization selectively impaired slow skeletal muscle sarcomere <br /> numbers greatly reduced mybpc1 knockdown embryos, electron microscopy reveals normal <br /> sarcomere structure. <span id='am-2' about='protege:TO' typeof='owl:Thing'>To</span> evaluate effects human distal arthrogryposis mutations, mybpc1 mRNAs contain- <br /> ing corresponding human W236R Y856H MYBPC1 mutations injected embryos. Dominant- <br /> negative effects mutations suggested resultant mild bent body curvature, decreased <br /> motor activity, impaired overall survival compared overexpression wild-type RNA. These <br /> results demonstrate critical role mybpc1 slow skeletal muscle development establish zebrafish as <br /> a tractable model human distal arthrogryposis. <br />  <br />  <br />  <br />  <br /> INTRODUCTION                                                              distal arthrogryposis, remarkably studies addressed <br />                                                                           mechanism mutations cause limb contractures. <br /> Distal arthrogryposis syndromes group autosomal dom-                 Genes encoding myosin-binding protein C belong intra- <br /> inant disorders characterized non-progressive congenital               cellular immunoglobulin superfamily abundantly <br /> contractures distal limbs (1). Ten different distal arthro-        expressed muscle (9). Three genes encode myosin-binding <br /> gryposis syndromes described date, including                 protein C proteins human mouse genomes are <br /> distal arthrogryposis type 1 affects 10 000          expressed predominantly slow skeletal muscle (MYBPC1), <br /> individuals (2). Patients distal arthrogryposis type 1          fast skeletal muscle (MYBPC2) cardiac muscle (MYBPC3) <br /> contractures limited hands feet (1). The              (10,11). Cardiac MYBPC3 mutations described in <br /> majority genes implicated distal arthrogryposis                 1995 considered common causes <br /> pathogenesis far encode components sarcomere               human hypertrophic cardiomyopathy (12,13). More recently, <br /> contractile apparatus myofibers, including b-tropomyosin               mutations slow skeletal muscle MYBPC1 gene iden- <br /> (TPM2), troponin I type 2 (TNNI2), troponin T type 3 (TNNT3),             tified families autosomal dominant distal arthrogry- <br /> myosin heavy chain 3 (MYH3) (3&#226;&#8364;&#8220;6) myosin-binding                      posis type 1 <span id='am-81' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-82' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-83' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-89' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-149' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-156' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span>phenotype</span> includes severe congenital <br /> protein C1 (MYBPC1) (7). Mutations genes               clubfoot, vertical talus camptodactyly (7). The human <br /> in  40% distal arthrogryposis patients (8). Despite fre-       MYBPC1 W236R Y856H mutations located the <br /> quency sarcomeric gene mutations identified          myosin-binding protein C unique motif (M-motif) the <br />  <br /> &#226;&#710;&#8212; <br /> To correspondence addressed at: Department Neurology, Washington University School Medicine, 660 S Euclid Avenue, St. Louis, <br /> MO 63110, USA. Tel: +1 314 286 2789; Fax: +1 314 286 2894; Email: gurnettc@neuro.wustl.edu <br />  <br /> # The Author 2013. Published Oxford University Press. All rights reserved. <br /> For Permissions, email: journals.permissions@oup.com <br />  4968      Human Molecular Genetics, 2013, Vol. 22, No. 24 <br />  <br />  <br /> C-terminal C8 domain, respectively (7). Exogenous expression          mobility. Because mutations responsible distal arthro- <br /> of MYBPC1 containing mutations murine muscle                 gryposis predicted cause disease dominant-negative <br /> demonstrated correct sarcomeric localization MYBPC1                mechanism, functional motor activity assay used to <br /> mutant proteins (7), functional effects muta-     evaluate MYBPC1 gene mutations relevant variety <br /> tions evaluated. A recent report described homozy-      additional human disease genes. <br /> gous MYBPC1 nonsense mutations unrelated Bedoin <br /> families autosomal recessive lethal congenital contracture <br /> syndrome type 4 (14).                                                 RESULTS <br />    The myosin-binding protein C family proteins plays              Localization mybpc1 slow-twitch skeletal <br /> important structural regulatory roles muscle function          muscle sarcomere <br /> (reviewed 15). They provide filament stability interacting <br /> with titin rod portion sarcomeric myosin (light            The zebrafish genome contains single mybpc1 ortholog on <br /> meromyosin) C-terminal region (16,17). The myosin-        chromosome 4 68.9% nucleotide identity human <br /> binding protein C unique M-motif modulates contractility      MYBPC1. Mybpc1 transcripts detected early 9 h <br /> dynamic interactions head region (S2) myosin          postfertilization (hpf), present somite development <br /> actin (18&#226;&#8364;&#8220;20). Critical residues M-motif          myogenic differentiation 12 24 hpf and <br /> phosphorylated PKA PKC (21), presenting additional          abundant 24 72 hpf (Fig. 1A). Whole- <br /> mechanism myosin-binding protein C regulate              mount immunofluorescence using anti-Mybpc1 antibody <br /> contractility (22,23). In addition structural functions,     demonstrated sarcomeric localization zebrafish embryo skel- <br /> myosin-binding protein C1 interacts muscle-type creat-      etal muscles (Fig. 1B). Within skeletal muscle, mybpc1 was <br /> ine kinase, potentially allowing regulate energy homeostasis    uniquely expressed superficial slow-twitch axial muscles <br /> during muscle contraction coupling myofibril (22).          embryonic stages analyzed, consistent previously <br />    Although MYBPC3 mutations extensively studied            published situ data (28). Expression overlaps entirely with <br /> for role human hypertrophic cardiomyopathy (reviewed         slow-twitch myosin detected F59 antibody (29). <br /> in 24,25), research MYBPC1 mutations limited. Several         Mybpc1 protein localized C-zone skeletal muscle <br /> lines evidence suggest mechanism muta-           fibers observed characteristic doublet <span id='am-393' about='xsp:pattern' typeof='owl:Thing'>pattern</span> <br /> tions MYBPC1 MYBPC3 cause disease                  (Fig. 1C). <br /> different. First, MYBPC3 mutations consist predominantly of <br /> nonsense mutations predicted cause autosomal dom- <br /> inant hypertrophic cardiomyopathy haploinsufficiency          Mybpc1 knockdown results severe ventral body curvature <br /> (25&#226;&#8364;&#8220; 27), MYBPC3 missense mutations associated           To determine mybpc1 required normal zebrafish devel- <br /> with reduced MYBPC3 protein levels (26). In contrast,        opment, employed antisense MOs achieve knockdown <br /> only mutations MYBPC1 described distal            mybpc1 gene function. Splice-site translation start <br /> arthrogryposis type 1, autosomal dominantly inherited        site blocking MOs injected 1- 4-cell-stage <br /> missense mutations (7). While MYPBC1 nonsense mutations               embryos. The effectiveness mybpc1 MO downregulate <br /> have described autosomal recessive lethal congenital          Mybpc1 protein expression verified western blotting. <br /> contracture syndrome 4 (LCCS4), evidence              Mybpc1 morpholino reduced Mybpc1 protein expression level <br /> muscle disease heterozygote carriers (14). Secondly, vivo       embryos 1 2 days postfertilization (dpf) (Fig. 2A). <br /> experiments demonstrate single amino acid substitutions             Embryos injected 1 ng mybpc1 MO exhibited <br /> in MYBPC3 cause protein fail incorporate           mild ventral body curvature 2 dpf (data shown), injec- <br /> sarcomere, single amino acid substitutions                 tion 2 ng MOs resulted similar severe ventral <br /> MYBPC1 localize properly (7). Despite correct localiza-         body curvature (n &#194;&#188; 280; Fig. 2B). Because MOs resulted <br /> tion, however, mechanisms MYBPC1 mutations               identical phenotypes, subsequent experiments <br /> cause limb contractures characteristic distal arthrogrypo-     using splice-site MO. To confirm pheno- <br /> sis unknown. Genetic studies knockouts           type observed mybpc1 morphants consequence of <br /> conducted animal model prior               mybpc1 deficiency, rescued mybpc1 morphants coinjec- <br /> functional studies distal arthrogryposis sarcomeric gene           tion zebrafish mybpc1 mRNA sensitive to <br /> mutations reports genetically based animal models        splice-site MO. Embryos injected mybpc1 mRNA <br /> distal arthrogryposis, needed improve         revealed phenotypic changes compared control <br /> understanding disorder.                                       embryos (data shown). Co-injection mybpc1 MO zeb- <br />    In study, demonstrate mybpc1 required     rafish mybpc1 mRNA resulted rescue ventrally curved <br /> the development function slow skeletal muscle zebra-        phenotype  30% embryos (50 168 injected <br /> fish. Antisense morpholino oligonucleotide (MO)-mediated              embryos) (Fig. 2B). Morphant embryos exhibited pericar- <br /> depletion Mybpc1 expression results severe ventral body         dial edema poor growth eyes head (Fig. 2C). Some <br /> curvature, decreased motility early lethality,         mybpc1 morphants displayed massive cardiac edema was <br /> impaired sarcomere development greatly reduced myofibril         associated reduced heart rate, particularly 3 dpf. <br /> numbers. Furthermore, demonstrate human                  These phenotypes observed embryos injected <br /> MYBPC1 mutations exert dominant-negative effects                   control antisense MO. <br /> muscle function expressed zebrafish development,             We investigated presence chorion influ- <br /> resulting embryo mild curvature impaired        ences ventrally curved phenotype mybpc1 morphants. <br />                                                                                           Human Molecular Genetics, 2013, Vol. 22, No. 24           4969 <br />  <br />  <br />                                                                                       Mybpc1 morphants exhibited decreased survival rate com- <br />                                                                                       pared control embryos. Although .90% (72/80) control <br />                                                                                       MO-injected embryos survived 5 dpf, ,5% (6/174) of <br />                                                                                       mybpc1 morphant embryos survived 5 dpf, lived to <br />                                                                                       7 dpf, indicating mybpc1 knockdown embryonic lethal <br />                                                                                       (Fig. 3B). <br />                                                                                          In zebrafish, recognizable skeletal muscle activity is <br />                                                                                       spontaneous embryo coiling flipping appears between <br />                                                                                       20 28 hpf (31) slow-twitch muscle activity <br />                                                                                       (32). The frequency spontaneous body coiling reduced in <br />                                                                                       mybpc1 MO compared control MO-injected embryos at <br />                                                                                       24 hpf (8.32 + 0.33 versus 2.11 + 0.41, n &#194;&#188; 30, P , 0.0001). <br />                                                                                       Furthermore, body coiling weak mybpc1 MO, with <br />                                                                                       barely perceptible movements compared robust tail <br />                                                                                       movements seen control MO-injected embryos. <br />                                                                                          To quantify differences early motor activity, mea- <br />                                                                                       sured photomotor response, stereotypic series motor <br />                                                                                       behaviors response high-intensity light stimulus (33). <br />                                                                                       Presentation light stimulus induces brief strong <br />                                                                                       motor excitation embryos resolves  5 s the <br />                                                                                       stimulus. Basal activity measured 3 s the <br />                                                                                       light stimulus. Using testing parameters, basal <br />                                                                                       motor activity photomotor responses reduced in <br />                                                                                       mybpc1 MO compared control MO-injected embryos <br />                                                                                       (Fig. 3C Supplementary Material, Videos S1 S2). <br />                                                                                       These data suggest slow-twitch muscle function severely <br />                                                                                       affected reduction Mybpc1. <br />                                                                                          The zebrafish escape response tactile stimulation motor <br />                                                                                       activity appears later development, 72 hpf. <br />                                                                                       Control MO-injected embryos respond tactile stimulus with <br /> Figure 1. Localization mybpc1 slow skeletal muscle zebrafish control         rapid escape contraction. In contrast, knockdown mybpc1 <br /> embryos. (A) RT-PCR analysis mybpc1 mRNA expression zebrafish con- <br /> trols embryos different times fertilization. Transcription mybpc1 first <br />                                                                                       zebrafish embryos resulted loss touch sensitivity with <br /> becomes detectable 9 hpf. The expression level EF1a served               evidence skeletal muscle contraction response phys- <br /> loading control. (B) Whole-mount immunofluorescence staining anti-               ical stimulation (Fig. 3D). <br /> Mybpc1 antibody zebrafish control embryos 1 dpf shows sarcomeric local- <br /> ization. (C) Immunohistochemical staining transverse sections control <br /> embryos anti-Mybpc1 antibody slow muscle myosin heavy chain anti-            Slow skeletal muscle myofibrils disorganized <br /> body F59 zebrafish embryos 2 dpf. Inset shows characteristic doublet        mybpc1 morphant embryos <br /> staining Mybpc1 C-zone sarcomere high power. <br />                                                                                       Because mybpc1 morphant movement severely impaired, <br />                                                                                       examined skeletal muscle evidence corre- <br /> To examine this, embryos dechorionated 8 hpf,  75%                         sponding structural abnormalities. At gross level, specification <br /> epiboly, growth occur potential con-                        slow fast muscles appeared unaffected mybpc1 knock- <br /> straint chorion. A relatively straight body axis present                   assessed antibodies directed slow- (F59) <br /> dechorionated control MO-injected embryos 1 dpf,                           fast-twitch (F310) muscle myosin heavy chains (Supplemen- <br /> the mybpc1 morphants ventral body curvature 1 dpf re-                         tary Material, Fig. S1). However, slow skeletal myofibers <br /> gardless presence absence chorion curvature                    located superficial embryo trunk grossly disar- <br /> remains development (Fig. 2D). Thus, ventral                           rayed size number myofibrils greatly reduced <br /> body curvature mybpc1 morphants independent                              mybpc1 morphant embryos (Fig. 4A). This stark con- <br /> intact chorion.                                                                       trast well-organized slow skeletal muscles myofibers of <br />                                                                                       control embryos. Central nuclei present morphant <br />                                                                                       embryo slow muscle. Electron microscopy demonstrated <br /> Defective motor activity mybpc1 morphants                                          disorganized myofibrils mybpc1 morphant embryos, <br /> We examined effects mybpc1 knockdown motor                             individual sarcomere ultrastructure appeared relatively <br /> activity zebrafish development. Embryos use muscular                           normal regularly aligned A-bands, I-bands, Z-lines and <br /> movements (e.g. flip tail) release                        M-lines (Fig. 4B Supplementary Material, Fig. S2). This <br /> their outer chorion. Although approximately 95% control                            provides evidence mybpc1 required normal devel- <br /> MO-injected embryos hatched chorion 72 hpf,                          opment slow skeletal muscle myofibers, sarco- <br /> expected wild-type (WT) embryos (30), 50%                                meres themselves. <br /> mybpc1-MO-injected embryos hatched stage con-                               To define components skeletal muscle myofibril <br /> sistent decrease overall muscle activity (Fig. 3A).                         affected mybpc1 knockdown, whole-mount <br />  4970       Human Molecular Genetics, 2013, Vol. 22, No. 24 <br />  <br />  <br />  <br />  <br /> Figure 2. Mybpc1 knockdown results severe ventral body curvature heart edema. (A) Mybpc1 protein expression significantly reduced in <br /> mybpc1-MO-injected embryos 1 2 dpf compared control MO. (B) Morphology embryos injected control MO, mybpc1 splice-site MO and <br /> mybpc1 translation MO 3 dpf. Injection mybpc1 MOs induced ventral body curvature embryos, coinjection mybpc1 mRNA resulted partial <br /> rescue body curvature phenotype (last panel). (C) Mybpc1 morphant embryos cardiac edema defect growth eyes head. (D) The ventral <br /> body curvature phenotype present mybpc1-MO embryos 1 3 dpf dechorionated 8 hpf. <br />  <br />  <br /> immunofluorescence assays performed examine specific                    Morphological examinations heart mybpc1 morphant <br /> components sarcomere. Immunostaining F59 revealed                   embryo <br /> severely disrupted sarcomere formation filament organ-                Although Mybpc1 primarily slow-twitch skeletal <br /> ization slow muscles mybpc1 morphant embryos compari-                  muscle, expressed human, rabbit, rat bovine <br /> son controls (Fig. 4C D). Very sarcomeres                       hearts (34). Mybpc1 protein present zebrafish heart at <br /> detected slow myofibers mybpc1 knockdown embryos. In                      2 dpf detected anti-mybpc1-specific antibody (Supple- <br /> contrast, organization fast muscle sarcomeres                    mentary Material, Fig. 3A). The phenotype mybpc1 mor- <br /> altered mybpc1 morphants shown staining fast                      phants included grossly apparent cardiac edema, low heart rate <br /> muscle myosin-specific antibody F310 embryos 1 dpf                        cardiac enlargement misfolded, elongated morph- <br /> (Fig. 4E F). To determine mybpc1 loss affected organ-                ology (Supplementary Material, Fig. 3B). However, sarcomeres <br /> ization filaments slow muscle, immunostaining per- <br />                                                                                 appeared formed mybpc1 morphant heart demon- <br /> formed using anti-a-actin antibody. In mybpc1 deficient <br />                                                                                 strated whole-mount immunostaining using F59 myosin <br /> state, filaments stained anti-a-actin antibody <br />                                                                                 heavy chain antibody, suggesting mybpc1 required <br /> showed poor organization little staining sarcomeric struc- <br />                                                                                 filament assembly heart. <br /> tures mybpc1-MO embryos compared control MO- <br /> injected embryos (Fig. 4G H). <br />    To understand role mybpc1 organization of <br /> other basic sarcomeric structures, analyzed localization                 Dominant-negative effects Mybpc1 mutant <br /> of Z- M-line-specific proteins a-actinin myomesin,                  protein expression <br /> respectively. Similar a-actin staining, sarcomeric locali-               Because previously showed MYBPC1 mutant proteins <br /> zations a-actinin Z-line myomesin M-line                      incorporate correctly sarcomeres (7), hypothesized <br /> were present, markedly reduced, mybpc1 morphants                         human mutations cause disease through <br /> (Fig. 4I &#226;&#8364;&#8220;L).                                                                   gain-of-function effects muscle function. Multiple <br />                                                                                     Human Molecular Genetics, 2013, Vol. 22, No. 24                   4971 <br />  <br />  <br />  <br />  <br /> Figure 3. Defective motor activity mybpc1 morphants. (A) Hatching delayed mybpc1-MO-injected embryos compared uninjected control <br /> MO-injected embryos. (B) Survival curve showing reduced survival mybpc1 morphant embryos surviving past 5 dpf. (C) Photomotor response assay <br /> demonstrating blunted motor response mybpc1-MO-injected embryos compared control MO-injected embryos 3-s light stimulus 30 hpf. <br /> Data represent cumulative motor activity 10 embryos recorded single assay. (D) Touch-escape response demonstrates rapid escape response in <br /> embryos injected control MO compared lack response mybpc1 morphants 3 dpf. <br />  <br />  <br /> alignments revealed human DA1 MYBPC1 mutations                            40/129) Y845H (26%, n &#194;&#188; 33/124) mRNAs rarely <br /> W236R Y856H highly conserved, therefore, cor-                  observed control, WT mybpc1 embryos injected the <br /> responding W220R Y845H mutations introduced                      H494Q mRNA corresponding human common polymorph- <br /> the zebrafish mybpc1 sequence (Fig. 5A). As negative control,                ism (Fig. 5B C). <br /> we introduced zebrafish mybpc1 sequence <span id='am-159' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-160' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span>mutation</span>                      To determine bent body phenotypes mutant <br /> (H494Q), corresponds MYBPC1 H506Q human poly-                         embryos associated abnormal skeletal muscle myofiber <br /> morphism (rs3817552) present overall minor allele                organization, performed filament immunostaining for <br /> frequency 0.176. Because high frequency humans,                   muscle myosin heavy chains. Embryos injected either <br /> the H494Q mutation zebrafish Mybpc1 likely benign.                 W220R Y845H-mybpc1 mRNA showed slow muscle fibers <br />    Mutant mRNAs corresponding distal arthrogryposis                   undulated tightly compacted compared with <br /> mutations injected zebrafish embryos order deter-              control uninjected WT-mybpc1 mRNA-injected embryos <br /> mine presence dominant-negative gain-of-function                     (Fig. 5D). At ultrastructural level, components sarco- <br /> effects muscle activity. Overexpression WT-mybpc1                        mere appeared unchanged compared muscle control unin- <br /> mRNA did result phenotype compared uninjected                  jected WT-mybpc1 RNA-injected embryos (Fig. 5E). <br /> control embryos. However, bent body phenotype observed                   Myofibers organized normal quantity. In contrast to <br /> at 4 dpf embryos injected W220R (31%, n &#194;&#188;                  structural changes seen slow-twitch muscle, fast skeletal <br />  4972       Human Molecular Genetics, 2013, Vol. 22, No. 24 <br />  <br />  <br />  <br />  <br /> Figure 4. Mybpc1 morphant embryos myofibril disorganization slow skeletal muscle. (A) Reduced size number myofibrils observed mybpc1 <br /> morphants compared control embryos 2 dpf light microscopy. Central nuclei present. (B) Ultrastructural examination mybpc1 morphant slow muscle <br /> shows disorganized myofibrils compared control embryos low power electron microscopy (top images, scale bar equals 2 mm). Higher power images dem- <br /> onstrate relatively normal appearing sarcomeres (bottom images, scale bar equals 1 mm). (C&#226;&#8364;&#8220;L) Whole-mount immunostaining control mybpc1 morphant <br /> embryos slow muscle myosin filament (F59) (C D), fast muscle myosin filament (F310) (E F), filament actin (G H), Z-line <br /> a-actinin (I J) M-line myomesin (K L) 1 dpf. The scale bars represent 20 mm. <br />  <br />  <br />  <br /> muscle appeared morphologically normal embryos expressing                     RNA-injected embryos responded normally rapidly swimming <br /> mutant protein assessed myosin heavy chain antibody                    field, W220R Y845H mutants consistently <br /> at 4 dpf (Supplementary Material, Fig. S4).                                      moved body lengths touched (data shown). <br />    Overexpression human distal arthrogryposis mutant                     Embryos injected mybpc1 mutant W220R Y845H <br /> mybpc1 mRNAs negatively affected embryonic motor activity                        mRNA failed survive past 10 dpf, suggesting the <br /> throughout embryonic development. Spontaneous body coiling                       motor deficits having significant effects overall sur- <br /> frequency 24 hpf reduced W220R (6.45 + 0.61, n &#194;&#188;                       vival (Fig. 5G). While mild heart edema seen the <br /> 60, P , 0.01) Y845H-mybpc1 (6.90 + 0.75, n &#194;&#188; 60, P ,                         mutant-injected embryos, embryos noted have <br /> 0.01) RNA-injected embryos compared control uninjected                      severe heart edema reduced heart rates (data shown). <br /> embryos (8.95 + 0.61, n &#194;&#188; 60). Likewise, hatching delayed <br /> in embryos injected W220R (16%; 11/65) or <br /> Y845H-mybpc1 (16%; 10/62) RNA compared control unin- <br /> jected embryos (50%; 44/88) 2 dpf, nearly embryos                DISCUSSION <br /> were hatched 3 dpf.                                                           Although myosin-binding protein C discovered skeletal <br />    When slow muscle activity quantified using photo-                muscle nearly 40 years ago, function remains poorly under- <br /> motor response 30 hpf, embryos injected W220R                 stood (9). Our results demonstrate slow skeletal <br /> or Y845H-mybpc1 RNA demonstrated statistically significant re-                   muscle mybpc1 gene essential normal zebrafish embryonic <br /> duction motor excitation compared control uninjected                 development. In fact, mybpc1 morphant embryonic pheno- <br /> WT-mybpc1 RNA-injected embryos (Fig. 5F Supplementary                        type remarkably similar recently <br /> Material, Fig. S5). However, reduced motor response                   described fetuses autosomal recessive lethal congenital <br /> mybpc1 mutant RNA-injected embryos dramatic                        contractural syndrome type 4 (LCCS4) homozygous non- <br /> that observed mybpc1-MO-injected embryos. As expected,                        sense mutations MYBPC1 (14). <br /> overexpression H494Q-mybpc1 variant corresponding                         We demonstrate dominant-negative effects human <br /> common human MYBPC1 gene polymorphism did                           distal arthrogryposis MYBPC1 missense mutations endogen- <br /> effect zebrafish motor activity. Touch-escape response                    ous sarcomeric proteins. While curved phenotype as <br /> also impaired mutant RNA-injected embryos compared                        penetrant severe seen mybpc1 morphants, <br /> with WT-mybpc1 RNA-injected embryo assessed                          embryos overexpressing zebrafish mybpc1 W220R and <br /> 3 dpf. Although control uninjected WT-mybpc1                              Y845H mutations (corresponding W236R Y856H <br />                                                                                       Human Molecular Genetics, 2013, Vol. 22, No. 24                    4973 <br />  <br />  <br />  <br />  <br /> Figure 5. Dominant-negative effects MYBPC1 human distal arthrogryposis mutations morphology motor function. (A) Location human distal arthro- <br /> gryposis mutations W236R Y856H benign common polymorphism rs3817552 corresponding zebrafish mutations. Immunoglobulin domains are <br /> shown circles fibronectin type III domains squares. (B) Percentage embryos bent body phenotype group embryos injected the <br /> indicated mybpc1 mRNAs. Embryos injected W220R Y845H-mybpc1 showed highest frequency bent body phenotype. (C) Zebrafish overexpressing <br /> W220R Y845H-mybpc1 mutations bent body phenotype 4 dpf. No curve present control uninjected zebrafish, zebrafish overexpressing WT <br /> mybpc1 mybpc1 containing common human polymorphism H494Q. (D) Abnormal slow muscle fiber organization W220R Y845H-mybpc1 mutant <br /> embryos showing wavy myofibers increased distance fibers shown whole-mount immunostaining antibody slow muscle myosin (F59) <br /> at 4 dpf. (E) Sarcomere ultrastructure unchanged compared control uninjected WT-mybpc1 RNA overexpressing embryos evaluated electron <br /> microscopy. (F) Embryos overexpressing W220R Y845H-mybpc1 decreased motor excitation response light stimulus compared control or <br /> WT-mybpc1 overexpressing embryos measured mean motion index separate batches injected embryos. Embryos overexpressing the <br /> H494Q-mybpc1 common human polymorphism similar photomotor response control uninjected WT-mybpc1 embryos (&#226;&#710;&#8212; P , 0.05; &#226;&#710;&#8212;&#226;&#710;&#8212; P , 0.01). <br /> (G) Decreased survival embryos overexpressing W220R Y845H-mybpc1 assessed 7 dpf (&#226;&#710;&#8212; P , 0.01). <br />  <br />  <br /> human MYBPC1 mutations) severe motor deficits                      potential functions needed determine mechanism by <br /> consequence, decreased survival. As previously observed                       distal arthrogryposis MYBPC1 mutations disrupt sarco- <br /> normal sarcomeric localization mutant human MYBPC1                            meric function. <br /> mutations (W236R Y856H) vivo (7), distal arthrogryposis                      In contrast dominant-negative effects MYBPC1 muta- <br /> mutations exert effects altering sarcomere stability              tions muscle function, vast majority MYBPC3 mutations <br /> modifying skeletal muscle contractility interaction                  associated human hypertrophic cardiomyopathy cause <br /> with sarcomeric proteins. Myosin-binding protein C inter-                  disease gene haploinsufficiency (25,36). Although the <br /> acts directly light meromyosin, actin, titin myosin                 allelic series MYBPC1 mutations small make con- <br /> head region (S2) (reviewed 15), providing multiple poten-                   clusions range types mutations causing distal <br /> tial interactions altered human mutations.                  arthrogryposis, MYBPC1 haploinsufficiency reported to <br /> In fact, Ackermann et al. recently reported                      cause muscle disease heterozygous parents relatives of <br /> human distal arthrogryposis mutations alter ability recom-                fetuses lethal congenital contractural syndrome to <br /> binant MYBPC1 fragments interact myosin actin                        homozygous MYBPC1 nonsense mutations (14). Because <br /> in vitro, abolishing actomyosin regulatory properties                MYBPC1 mutations appear cause disease potentially <br /> (35). Further studies directed investigating                    different mechanism MYBPC3 mutations, functional studies <br />  4974      Human Molecular Genetics, 2013, Vol. 22, No. 24 <br />  <br />  <br /> of distal arthrogryposis hypertrophic cardiomyopathy          useful testing functional consequences human mutations <br /> mutations likely provide complementary insights        robust motor phenotype. Because distal <br /> unique properties proteins.                                    arthrogryposis-associated genes associated extensive <br />     The presence cardiac edema, reduced heart rate, abnor-      genetic variation controls muscle disease (3), <br /> mal heart looping mybpc1 morphant fish suggests       distinguishing normal variants pathogenic <br /> mybpc1 necessary early heart development,          poses major challenge. Since mutations distal <br /> it possible findings non-specific secondary   arthrogryposis-associated genes predicted cause <br /> impaired mobility. Although early studies failed evidence      dominant-negative effects, quantitative assay describe <br /> for Mybpc1 expression murine human heart (37), Mybpc1            used study functional effects variants <br /> protein expression recently shown normal adult             currently classified unknown significance <br /> mammalian heart (34). Here, demonstrate Mybpc1 protein              variety human disease genes. <br /> expression early zebrafish cardiac development. Interest-          This study addresses need tractable models human <br /> ingly, <span id='am-315' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-316' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-317' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-318' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-319' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-320' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-321' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-322' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-323' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-324' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-326' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-327' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-329' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-331' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-332' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-333' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-334' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-335' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-336' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-338' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-339' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-343' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-345' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-346' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-347' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-350' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-355' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-356' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-358' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-359' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-360' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-362' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-364' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-366' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-367' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-369' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-371' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-375' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-377' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-378' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-379' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-380' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-381' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-383' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-385' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-387' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-388' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-389' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-391' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span>lethal phenotype</span> observed mybpc1 morphant            arthrogryposis demonstrates zebrafish effectively <br /> fish lies contrast lack apparent early developmen-    model effects MYBPC1 mutations associated lethal <br /> tal phenotype cardiac mybpc3 expression abolished          congenital contracture syndrome distal arthrogryposis. Our <br /> mice (38). Thus, mybpc1 sufficient support normal            current findings provide evidence dominant-negative and <br /> cardiac development absence mybpc3 expression.               loss-of-function mutations MYBPC1 result distal arthrogry- <br />     Human contractures distal arthrogryposis hypothesized       posis lethal congenital contracture syndrome type 4, respect- <br /> to reduced movement utero. We demonstrate as-          ively, establish critical role MYBPC1 embryonic <br /> sociation impaired motor activity curved body phe-         muscle development. As studies arthrogryposis <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> notypes mybpc1 morphant zebrafish embryos              gene discovery translational development novel treat- <br /> overexpressing mybpc1-distal arthrogryposis mutations. The             ment methods, zebrafish models likely valuable <br /> mybpc1 morphants predominantly ventral body curva-              tools identification disease-modifying pharmaceuticals <br /> ture, zebrafish deficits motor activity       useful new treatments patients congeni- <br /> are dorsally curved, including zebrafish neb embryos          tal contracture syndromes. <br /> (39), slow muscle-specific a-actinin-2 morphant (40) and <br /> mtm1 morphants (41). However, absent movement 24 hpf <br /> does itself appear sufficient development         MATERIALS AND METHODS <br /> of curved phenotype. For example, zebrafish smyhc1 (slow             Zebrafish embryo maintenance <br /> skeletal muscle myosin heavy chain) morphants paralyzed <br /> at 24 hpf normal straight body phenotype (42). Fur-         Wild-type zebrafish (Danio rerio) maintained embryos <br /> thermore, significance ventral curved zebrafish pheno-      raised described (47). The wild-type AB fish were <br /> type complicated non-specific nature, similar      obtained Zebrafish International Resource Center. Fish <br /> curved shape reported zebrafish models muscu-         anesthetized squeezing using tricaine methanesulfonate <br /> lar dystrophy (43&#226;&#8364;&#8220; 45). Future studies needed determine         (3-amino benzoic acidethylester, Sigma) final concentration <br /> whether alterations distal arthrogryposis-associated sar-     0.16% E3 embryo medium (5 mM NaCl, 0.17 mM KCl, <br /> comeric genes, including MYH3, TNNT3, TPM2 TNNI2,                  0.33 mM CaCl2, MgSO4 H2O). All animal work approved <br /> result similar embryonic curved phenotypes          animal studies committee Washington University. <br /> motor deficits concordant change body axis. <br />     Because human contractures associated con- <br /> strained fetal movement (46), wondered pres-            Microinjection MOs mRNA embryos <br /> ence intact chorion contributed highly curved             All antisense MOs targeting zebrafish mybpc1 purchased <br /> phenotype observed mybpc1-morphant fish. Thus,            Gene Tools, LLC (Philomath, OR, USA). The sequences <br /> taking advantage unique aspects zebrafish development            standard control mybpc1 MOs targeting intron 3&#226;&#8364;&#8220;exon 4 <br /> and removing chorion, showed contracted pheno-         (splice-blocking) ATG start codon (translation-blocking) <br /> type mybpc1 morphants primarily result abnor-        follows: standard control, 5&#226;&#8364;&#178; -CCTCTTACCTCAG <br /> mal muscle development contribution                TTACAATTTATA-3&#226;&#8364;&#178; ; splice-blocking MO, 5&#226;&#8364;&#178; -TATCATCTG <br /> presence intact chorion.                                         AACAGAGACAGAGAGA-3&#226;&#8364;&#178; ; translation-blocking MO, 5&#226;&#8364;&#178; -GC <br />     In addition providing tool basic mechanisms      TCAGGCATGTTGAGCCGTTCTCC-3&#226;&#8364;&#178; . The 3&#226;&#8364;&#178; end standard <br /> of contracture formation studied, zebrafish model        control splice-blocking MOs modified Lissamine <br /> distal arthrogryposis used quantify deleterious     tag. MOs dissolved nuclease-free water, 1 nl (2 ng) <br /> effects human MYBPC1 gene variants. By quantitatively               injected 1- 4-cell-stage embryos. <br /> measuring embryonic motor function response light                 For overexpression wild-type mutant zebrafish <br /> stimulus, able distinguish deleterious              mybpc1, coding region zebrafish mybpc1 mRNA was <br /> human disease causing mutations benign MYBPC1 poly-              cloned pCS2+ multiple expression vector. W220R, <br /> morphism effect motor function. Since               Y845H H494Q mutant zebrafish mybpc1 constructs were <br /> mutant RNA injected early development, mutant            generated using QuickChange Site-Directed Mutagenesis Kit <br /> proteins likely expressed muscle, including cardiac,        (Stratagene) according manufacturer&#226;&#8364;&#8482;s protocol. <br /> fast slow muscle; therefore, approach likely does         mRNAs synthesized using mMESSAGE mMACHINE <br /> yield fully accurate human disease model. Yet, remains            (Ambion) injected embryos 1 &#226;&#8364;&#8220; 4 cell stages. <br />                                                                         Human Molecular Genetics, 2013, Vol. 22, No. 24            4975 <br />  <br />  <br /> Reverse transcription &#226;&#8364;&#8220;polymerase chain reaction                    Touch-escape response assay <br /> To measure mRNA expression mybpc1, RNA prepared          Mechanosensory stimuli delivered 3 dpf embryos <br /> from zebrafish embryos using RNeasy Mini Kit (Qiagen). RNA          insect pins. Embryonic behaviors recorded using <br /> was reverse transcribed converted complementary            BB FlashBack Express Recorder software (Bluberry Software) <br /> DNA (cDNA) using superscript II Reverse Transcription Kit       dissection microscope (Olympus DP70). Time-lapse <br /> (Invitrogen) according manufacturer&#226;&#8364;&#8482;s protocol. Reverse      images embryonic behavior exported using BB <br /> transcription&#226;&#8364;&#8220;polymerase chain reaction (RT-PCR) per-           FlashBack Express Player software (Blueberry Software). <br /> formed using following primers: mybpc1, 5&#226;&#8364;&#178; -TTTGCC <br /> AAGAGATTGGAACC-3&#226;&#8364;&#178; 5&#226;&#8364;&#178; -GATGTGCACTTTGGCA <br /> GAGA-3&#226;&#8364;&#178; ; EF1a, 5&#226;&#8364;&#178; -GATGCACCACGAGTCTCTGA-3&#226;&#8364;&#178;                     Western blotting <br /> 5&#226;&#8364;&#178; -TGATGACCTGAGCGTTGAAG-3&#226;&#8364;&#178; .                                       Embryos dechorionated deyolking buffer (55 mM NaCl, <br />                                                                     1.8 mM KCl, 1.25 mM NaHCO3) homogenized lysis <br />                                                                     buffer (20 mM Tris&#226;&#8364;&#8220;HCl, pH 7.4, 1% Triton X-100, 150 mM <br />                                                                     NaCl) complete protease inhibitor cocktail (Roche Applied <br /> Immunofluorescence staining                                         Sciences). Total lysates separated sodium dodecyl <br /> For immunohistochemistry, embryos 1 2 dpf         sulfate&#226;&#8364;&#8220;polyacrylamide gel electrophoresis (SDS&#226;&#8364;&#8220;PAGE), and <br /> dechorionated protease type XIV (Sigma). Embryos            transferred nitrocellulose membrane. Membrane were <br /> fixed 4% paraformaldehyde (PFA) overnight 48C,              blocked 5% skim milk 1 h incubated anti-Mybpc1 <br /> embedded agarose Tissue-Tek O.C.T. medium (Sakura            anti-a-tubulin (DSHB) antibody overnight 48C. Membranes <br /> Finetek USA). Then, blocks containing embryos          washed 0.1% PBST (0.1% Tween 20 PBS) incu- <br /> frozen liquid nitrogen-chilled methyl butane sectioned.      bated secondary antibody conjugated horseradish perox- <br /> The sections permeabilized 0.1% Triton X-100, 1%          idase 2 h RT. Blots developed chemiluminescent <br /> BSA, 1% DMSO PBS 10 min, blocked blocking               substrate enhanced chemiluminescence (GE Healthcare). <br /> solution (2% normal goat serum PBS) 30 min incu- <br /> bated anti-MYBPC1 (abcam Cat# ab55559), anti-F59 (De- <br /> velopmental Studies Hybridoma Bank) (DSHB) anti-F310             Birefringence assay <br /> (DSHB) antibody blocking solution overnight 48C. After        Muscle birefringence analyzed placing anesthetized <br /> three washes PBS, sections incubated             embryos glass polarizing filter covering a <br /> AlexaFluor488-conjugated secondary antibody 2 h RT.          second polarizing filter ZEISS AXIOSKOP microscope <br /> For whole-mount immunofluorescence, embryos placed             (Carl Zeiss). The polarizing filter twisted the <br /> in 4% PFA 1 h RT, washed 1% Triton X-100 PBS,          light refracting striated muscle visible (48). <br /> and permeabilized ice cold acetone 8 min. After incubation <br /> in blocking solution (10% FBS, 1% Triton X-100 PBS) 1 h <br /> at RT, embryos immunostained anti-Mybpc1 (abcam,          Histology electron microscopy <br /> ab55559), anti-F59 (DSHB) anti-F310 (DSHB), anti-actin           Anesthetized embryos chemically fixed immersion in <br /> (American Research Products), anti-a-actinin (Sigma) anti-       3% glutaraldehyde 0.1 M cacodylate buffer 3 h. After <br /> myomesin (DSHB) antibody blocking solution overnight          rinsing cacodylate buffer, fixed 2% osmium <br /> 48C. Then, embryos washed 1% Triton X-100 PBS            tetroxide buffer, rinsed water, dehydrated in <br /> three times incubated AlexaFluor488-conjugated             acetone series embedded Araldite (Ted Pella). For light <br /> secondary antibody overnight 48C. Following staining,            microscopy, 0.5&#226;&#8364;&#8220; 0.7 mm sections cut stained <br /> embryos imaged using FV1000 confocal microscope                toluidene blue imaged Leica DM2500 microscope <br /> (Olympus).                                                          fitted camera running Leica Application Suite. For elec- <br />                                                                     tron microsopy, sections,  100 nm thick, cut a <br />                                                                     Reichert Ultracut E ultramicrotome, picked uncoated <br />                                                                     700-mesh hexagonal grids stained uranyl acetate <br /> Measurement spontaneous coiling rate motion index            (1:1, 2% uranyl acetate:ethanol, 30 min) followed Reynolds <br /> Spontaneous coiling rate recorded number events       lead citrate (30 min). They imaged Jeol 1200 EX <br /> observed 15 s embryo. Motion index zebrafish         electron microscopy fitted Tietz FastScan CCD camera <br /> embryos measured previously described              running TVIPS software (Tietz). Great care taken distin- <br /> modifications (33). Embryonic behaviors recorded            guishing slow fibers fast fibers. Slow fibers superficial, <br /> 30 frames/s using BB FlashBack Express Recorder software            fast fibers deeper. Slow fibers fish run parallel to <br /> (Bluberry Software) dissecting microscope (Olympus          axis fish fast fibers run parallel myotomes, <br /> DP70). To analyze movement embryo, ImageJ soft-         appearance barbed end arrow (49). <br /> ware used convert frame black-and-white image. <br /> Then, software tracked light intensity embryo <br /> over 30 s. Motion index represents mean absolute         Statistical analysis <br /> value difference light intensity adjacent time    Differences coiling frequency, mean motion index, sur- <br /> points measured 30 times/s embryo. All experi-      vival quantified one-way ANOVA. All error bars <br /> ments performed triplicate.                                 shown represent standard error mean. <br />  4976        Human Molecular Genetics, 2013, Vol. 22, No. 24 <br />  <br />  <br /> SUPPLEMENTARY MATERIAL                                                                 14. Markus, B., Narkis, G., Landau, D., Birk, R.Z., Cohen, I. Birk, O.S. <br />                                                                                            (2012) Autosomal recessive lethal congenital contractural syndrome type 4 <br /> Supplementary Material available HMG online.                                         (LCCS4) caused mutation MYBPC1. Hum. Mut., 33, 1435&#226;&#8364;&#8220;1438. <br />                                                                                        15. James, J. Robbins, J. (2011) Signaling myosin-binding protein C. <br />                                                                                            J. Biol. Chem., 286, 9913&#226;&#8364;&#8220;9919. <br />                                                                                        16. Okagaki, T., Weber, F.E., Fischman, D.A., Vaughan, K.T., Mikawa, T. and <br /> ACKNOWLEDGEMENTS                                                                           Reinach, F.C. (1993) The major myosin-binding domain skeletal muscle <br />                                                                                            MyBP-C (C protein) resides COOH-terminal, immunoglobulin C2 <br /> This work supported grants Shriners Hospital,                          motif. J. Cell Biol., 123, 619&#226;&#8364;&#8220;626. <br /> Children&#226;&#8364;&#8482;s Discovery Institute Washington University                            17. Freiburg, A. Gautel, M. (1996) A molecular map interactions <br />                                                                                            titin myosin-binding protein C. Implications sarcomeric <br /> St. Louis Children&#226;&#8364;&#8482;s Hospital. P.K.L. A.V. acknowledge                             assembly familial hypertrophic cardiomyopathy. Eur. J. Biochem., 235, <br /> support funding British Heart Foundation (RG/11/                               317&#226;&#8364;&#8220;323. <br /> 21/29335) EC Grant Agreement n. 241577 (BIG-Heart)                                 18. Gruen, M. Gautel, M. (1999) Mutations beta-myosin S2 cause <br /> FP7 Seventh Framework Programme Health. The Zebrafish Inter-                               familial hypertrophic cardiomyopathy (FHC) abolish interaction <br /> national Resource Center supported grant P40 RR012546                                regulatory domain myosin-binding protein-C. J. Mol. Biol., 286, <br />                                                                                            933&#226;&#8364;&#8220;949. <br /> from NIH-NCRR. We thank Dr Lila Solnica-Krezel                                 19. Moos, C., Mason, C.M., Besterman, J.M., Feng, I.N. Dubin, J.H. (1978) <br /> Kelly Monk reviewing manuscript Doug Oppedal                                   The binding skeletal muscle C-protein F-actin, relation the <br /> for help maintaining zebrafish.                                                    interaction actin myosin subfragment-1. J. Mol. Biol., 124, 571&#226;&#8364;&#8220;586. <br />                                                                                        20. Oakley, C.E., Chamoun, J., Brown, L.J. Hambly, B.D. (2007) Myosin <br /> Conflict Interest statement. None declared.                                             binding protein-C: enigmatic regulator cardiac contraction. <br />                                                                                            Int. J. Biochem. Cell Biol., 39, 2161&#226;&#8364;&#8220;2166. <br />                                                                                        21. Ackermann, M.A. Kontrogianni-Konstantopoulos, A. (2011) Myosin <br />                                                                                            binding protein-C slow novel substrate protein kinase A (PKA) C <br />                                                                                            (PKC) skeletal muscle. J. Proteome Res., 10, 4547&#226;&#8364;&#8220; 4555. <br /> REFERENCES                                                                             22. Chen, Z., Zhao, T.J., Li, J., Gao, Y.S., Meng, F.G., Yan, Y.B. Zhou, H.M. <br />  1. Bamshad, M., Van Heest, A.E. Pleasure, D. (2009) Arthrogryposis:                 (2011) Slow skeletal muscle myosin-binding protein-C (MyBPC1) mediates <br />     review update. J. Bone Joint Surg. Am., 91, 40&#226;&#8364;&#8220; 46.                                recruitment muscle-type creatine kinase (CK) myosin. Biochem. J., <br />  2. Hall, J.G. (1985) Genetic aspects arthrogryposis. Clin. Ortho. Relat. Res.,         436, 437&#226;&#8364;&#8220; 445. <br />     194, 44&#226;&#8364;&#8220; 53.                                                                       23. Colson, B.A., Rybakova, I.N., Prochniewicz, E., Moss, R.L. Thomas, <br />  3. Toydemir, R.M., Rutherford, A., Whitby, F.G., Jorde, L.B., Carey, J.C.             D.D. (2012) Cardiac myosin binding protein-C restricts intrafilament <br />     Bamshad, M.J. (2006) Mutations embryonic myosin heavy chain (MYH3)                  torsional dynamics actin phosphorylation-dependent manner. Proc. <br />     cause Freeman-Sheldon syndrome Sheldon-Hall syndrome. Nat. Genet.,                 Natl Acad. Sci. USA, 109, 20437&#226;&#8364;&#8220;20442. <br />     38, 561&#226;&#8364;&#8220; 565.                                                                      24. Barefield, D. Sadayappan, S. (2010) Phosphorylation function of <br />  4. Tajsharghi, H., Kimber, E., Holmgren, D., Tulinius, M. Oldfors, A.                 cardiac myosin binding protein-C health disease. J. Mol. Cell. <br />     (2007) Distal arthrogryposis muscle weakness associated                     Cardiol., 48, 866&#226;&#8364;&#8220;875. <br />     beta-tropomyosin mutation. Neurology, 68, 772 &#226;&#8364;&#8220;775.                                25. Marston, S., Copeland, O., Gehmlich, K., Schlossarek, S. Carrier, L. <br />  5. Sung, S.S., Brassington, A.M., Grannatt, K., Rutherford, A., Whitby, F.G.,             (2012) How MYBPC3 mutations cause hypertrophic cardiomyopathy? <br />     Krakowiak, P.A., Jorde, L.B., Carey, J.C. Bamshad, M. (2003)                       J. Muscle Res. Cell Motil., 33, 75&#226;&#8364;&#8220;80. <br />     Mutations genes encoding fast-twitch contractile proteins cause distal          26. Marston, S., Copeland, O., Jacques, A., Livesey, K., Tsang, V., McKenna, <br />     arthrogryposis syndromes. Am. J. Hum. Genet., 72, 681&#226;&#8364;&#8220;690.                             W.J., Jalilzadeh, S., Carballo, S., Redwood, C. Watkins, H. (2009) <br />  6. Sung, S.S., Brassington, A.M., Krakowiak, P.A., Carey, J.C., Jorde, L.B.           Evidence human myectomy samples MYBPC3 mutations cause <br />     Bamshad, M. (2003) Mutations TNNT3 cause multiple congenital                        hypertrophic cardiomyopathy haploinsufficiency. Circ. Res., 105, <br />     contractures: second locus distal arthrogryposis type 2B. Am. J. Hum.            219&#226;&#8364;&#8220;222. <br />     Genet., 73, 212&#226;&#8364;&#8220; 214.                                                              27. van Dijk, S.J., Dooijes, D., dos Remedios, C., Michels, M., Lamers, J.M., <br />  7. Gurnett, C.A., Desruisseau, D.M., McCall, K., Choi, R., Meyer, Z.I.,                   Winegrad, S., Schlossarek, S., Carrier, L., Cate, F.J., Stienen, G.J. et al. <br />     Talerico, M., Miller, S.E., Ju, J.S., Pestronk, A., Connolly, A.M. et al. (2010)       (2009) Cardiac myosin-binding protein C mutations hypertrophic <br />     Myosin binding protein C1: novel gene autosomal dominant distal                  cardiomyopathy: haploinsufficiency, deranged phosphorylation, and <br />     arthrogryposis type 1. Hum. Mol. Genet., 19, 1165&#226;&#8364;&#8220;1173.                                cardiomyocyte dysfunction. Circulation, 119, 1473&#226;&#8364;&#8220;1483. <br />  8. Beck, A.E., McMillin, M.J., Gildersleeve, H.I., Kezele, P.R., Shively, K.M.,       28. Xu, Y., He, J., Wang, X., Lim, T.M. Gong, Z. (2000) Asynchronous <br />     Carey, J.C., Regnier, M. Bamshad, M.J. (2013) Spectrum mutations                activation 10 muscle-specific protein (MSP) genes zebrafish <br />     cause distal arthrogryposis types 1 2B. Am. J. Med. Genet. A, 161,            somitogenesis. Dev. Dyn., 219, 201 &#226;&#8364;&#8220;215. <br />     550&#226;&#8364;&#8220; 555.                                                                          29. Miller, J.B., Teal, S.B. Stockdale, F.E. (1989) Evolutionarily conserved <br />  9. Offer, G., Moos, C. Starr, R. (1973) A new protein filaments          sequences striated muscle myosin heavy chain isoforms. Epitope mapping <br />     vertebrate skeletal myofibrils. Extractions, purification                       cDNA expression. J. Biol. Chem., 264, 13122&#226;&#8364;&#8220;13130. <br />     characterization. J. Mol. Biol., 74, 653&#226;&#8364;&#8220; 676.                                     30. Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B. Schilling, <br /> 10. Gautel, M., Zuffardi, O., Freiburg, A. Labeit, S. (1995) Phosphorylation           T.F. (1995) Stages embryonic development zebrafish. Dev. Dyn., <br />     switches specific cardiac isoform myosin binding protein-C:               203, 253&#226;&#8364;&#8220; 310. <br />     modulator cardiac contraction? EMBO J., 14, 1952&#226;&#8364;&#8220; 1960.                         31. Saint-Amant, L. Drapeau, P. (1998) Time course development of <br /> 11. Weber, F.E., Vaughan, K.T., Reinach, F.C. Fischman, D.A. (1993)                    motor behaviors zebrafish embryo. J. Neurobiol., 37, 622&#226;&#8364;&#8220;632. <br />     Complete sequence human fast-type slow-type muscle                          32. Naganawa, Y. Hirata, H. (2011) Developmental transition touch <br />     myosin-binding-protein C (MyBP-C). Differential expression, conserved                  response slow muscle-mediated coilings fast muscle-mediated burst <br />     domain structure chromosome assignment. Eur. J. Biochem., 216,                     swimming zebrafish. Dev. Biol., 355, 194 &#226;&#8364;&#8220;204. <br />     661&#226;&#8364;&#8220; 669.                                                                          33. Kokel, D., Bryan, J., Laggner, C., White, R., Cheung, C.Y., Mateus, R., <br /> 12. Bonne, G., Carrier, L., Bercovici, J., Cruaud, C., Richard, P., Hainque, B.,           Healey, D., Kim, S., Werdich, A.A., Haggarty, S.J. et al. (2010) Rapid <br />     Gautel, M., Labeit, S., James, M., Beckmann, J. et al. (1995) Cardiac myosin           behavior-based identification neuroactive small molecules the <br />     binding protein-C gene splice acceptor site mutation associated                zebrafish. Nat. Chem. Biol., 6, 231&#226;&#8364;&#8220;237. <br />     familial hypertrophic cardiomyopathy. Nat. Genet., 11, 438&#226;&#8364;&#8220; 440.                   34. Dhoot, G.K. Perry, S.V. (2005) Expression slow skeletal myosin <br /> 13. Watkins, H., Conner, D., Thierfelder, L., Jarcho, J.A., MacRae, C.,                    binding C-protein normal adult mammalian heart. J. Muscle Res. Cell <br />     McKenna, W.J., Maron, B.J., Seidman, J.G. Seidman, C.E. (1995)                     Motil., 26, 143&#226;&#8364;&#8220; 148. <br />     Mutations cardiac myosin binding protein-C gene chromosome 11            35. Ackermann, M.A., Patel, P.D., Valenti, J., Takagi, Y., Homsher, E., Sellers, <br />     cause familial hypertrophic cardiomyopathy. Nat. Genet., 11, 434&#226;&#8364;&#8220; 437.                 J.R. Kontrogianni-Konstantopoulos, A. (2013) Loss actomyosin <br />                                                                                               Human Molecular Genetics, 2013, Vol. 22, No. 24                         4977 <br />  <br />  <br />       regulation distal arthrogryposis myopathy mutant myosin binding          42. Codina, M., Li, J., Gutierrez, J., Kao, J.P. Du, S.J. (2010) Loss Smyhc1 <br />       protein-C slow. FASEB J., 27, doi:10.1096/fj.13-228882.                                Hsp90alpha1 function results different effects myofibril <br /> 36.   Carrier, L., Bonne, G., Bahrend, E., Yu, B., Richard, P., Niel, F., Hainque, B.,       organization skeletal muscles zebrafish embryos. PLoS ONE, 5, e8416. <br />       Cruaud, C., Gary, F., Labeit, S. et al. (1997) Organization sequence        43. Guyon, J.R., Mosley, A.N., Zhou, Y., O&#226;&#8364;&#8482;Brien, K.F., Sheng, X., Chiang, K., <br />       human cardiac myosin binding protein C gene (MYBPC3) identification                Davidson, A.J., Volinski, J.M., Zon, L.I. Kunkel, L.M. (2003) The <br />       mutations predicted produce truncated proteins familial hypertrophic          dystrophin associated protein complex zebrafish. Hum. Mol. Genet., 12, <br />       cardiomyopathy. Circ. Res., 80, 427 &#226;&#8364;&#8220;434.                                              601&#226;&#8364;&#8220; 615. <br /> 37.   Gautel, M., Furst, D.O., Cocco, A. Schiaffino, S. (1998) Isoform               44. Zhang, R., Yang, J., Zhu, J. Xu, X. (2009) Depletion zebrafish <br />       transitions myosin binding protein C family developing human             Tcap leads muscular dystrophy disrupting sarcomere-membrane <br />       mouse muscles: lack isoform transcomplementation cardiac muscle.                 interaction, sarcomere assembly. Hum. Mol. Genet., 18, <br />       Circ. Res., 82, 124&#226;&#8364;&#8220;129.                                                               4130&#226;&#8364;&#8220;4140. <br /> 38.   Harris, S.P., Bartley, C.R., Hacker, T.A., McDonald, K.S., Douglas, P.S.,          45. Telfer, W.R., Busta, A.S., Bonnemann, C.G., Feldman, E.L. Dowling, <br />       Greaser, M.L., Powers, P.A. Moss, R.L. (2002) Hypertrophic                         J.J. (2010) Zebrafish models collagen VI-related myopathies. Hum. Mol. <br />       cardiomyopathy cardiac myosin binding protein-C <span id='am-237' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-238' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-239' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-240' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-242' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-243' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-247' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-248' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-249' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-251' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-254' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-256' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-259' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-262' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-265' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-267' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-268' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-270' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-277' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-278' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-281' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-283' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-295' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-305' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span>knockout</span> mice. Circ.                Genet., 19, 243 <br /> </body></html>